Ameritas Investment Partners, Inc. Amylyx Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$18.08 - $23.45 $18,278 - $23,707	1,011 Added 25.06%	5,046 $92,000
Q4 2022 Feb 13, 2023	BUY	$29.75 - $39.26 $37,812 - $49,899	1,271 Added 45.98%	4,035 $149,000
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $34,643 - $62,458	2,020 Added 271.51%	2,764 $77,000
Q1 2022 May 13, 2022	BUY	$12.85 - $32.9 $9,560 - $24,477	744 New	744 $10,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.